NEWS

PRESS RELEASES

04.10.14:
Xencor Receives Milestone Payment from Merck for Initiation of Phase 1 Clinical Trial of a Biologic Candidate using XmAb® Antibody Engineering Intellectual Property

ARTICLES

10 Next-Gen Biologics Platforms: – FierceBiotech

EVENTS

05.05.14 – 05.09.14

PEGS Boston, Protein Engineering Summit (John Desjarlais, Ph.D., presenting; Boston, MA)